Detalhe da pesquisa
1.
Autoantigen Tetramer Silences Autoreactive B Cell Populations.
Mol Pharm
; 17(11): 4201-4211, 2020 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32903002
2.
Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders.
Mol Pharm
; 16(6): 2452-2461, 2019 06 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31083955
3.
Tocopherol Emulsions as Functional Autoantigen Delivery Vehicles Evoke Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis.
Mol Pharm
; 16(2): 607-617, 2019 02 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30615457
4.
Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis.
J Autoimmun
; 93: 76-88, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30007842
5.
Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune Encephalomyelitis.
Front Immunol
; 11: 603029, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33537031
6.
Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitis.
J Control Release
; 266: 156-165, 2017 Nov 28.
Artigo
Inglês
| MEDLINE | ID: mdl-28963036
7.
Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity.
Adv Drug Deliv Rev
; 98: 86-98, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26546466